219 related articles for article (PubMed ID: 31421864)
1. Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis.
Chiang FL; Wang Q; Yu FF; Romero RS; Huang SY; Fox PM; Tantiwongkosi B; Fox PT
Clin Radiol; 2019 Oct; 74(10):816.e19-816.e28. PubMed ID: 31421864
[TBL] [Abstract][Full Text] [Related]
2. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
[TBL] [Abstract][Full Text] [Related]
3. Gray matter changes in panic disorder: A voxel-based meta-analysis and meta-analytic connectivity modeling.
Wu Y; Zhong Y; Ma Z; Lu X; Zhang N; Fox PT; Wang C
Psychiatry Res Neuroimaging; 2018 Dec; 282():82-89. PubMed ID: 30340800
[TBL] [Abstract][Full Text] [Related]
4. Localised Grey Matter Atrophy in Multiple Sclerosis and Clinically Isolated Syndrome-A Coordinate-Based Meta-Analysis, Meta-Analysis of Networks, and Meta-Regression of Voxel-Based Morphometry Studies.
Singh S; Tench CR; Tanasescu R; Constantinescu CS
Brain Sci; 2020 Oct; 10(11):. PubMed ID: 33143012
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
6. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
7. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
[TBL] [Abstract][Full Text] [Related]
8. Chronic cigarette smoking is linked with structural alterations in brain regions showing acute nicotinic drug-induced functional modulations.
Sutherland MT; Riedel MC; Flannery JS; Yanes JA; Fox PT; Stein EA; Laird AR
Behav Brain Funct; 2016 Jun; 12(1):16. PubMed ID: 27251183
[TBL] [Abstract][Full Text] [Related]
9. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
[TBL] [Abstract][Full Text] [Related]
10. Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.
Laganá MM; Mendozzi L; Pelizzari L; Bergsland NP; Pugnetti L; Cecconi P; Baselli G; Clerici M; Nemni R; Baglio F
Curr Neurovasc Res; 2018; 15(4):282-291. PubMed ID: 30468125
[TBL] [Abstract][Full Text] [Related]
11. Convergent gray matter alterations across drugs of abuse and network-level implications: A meta-analysis of structural MRI studies.
Hill-Bowen LD; Riedel MC; Salo T; Flannery JS; Poudel R; Laird AR; Sutherland MT
Drug Alcohol Depend; 2022 Nov; 240():109625. PubMed ID: 36115222
[TBL] [Abstract][Full Text] [Related]
12. Subcortical grey matter structures in multiple sclerosis: what is their role in cognition?
Cruz-Gómez ÁJ; Aguirre N; Sanchis-Segura C; Ávila C; Forn C
Neuroreport; 2018 May; 29(7):547-552. PubMed ID: 29465624
[TBL] [Abstract][Full Text] [Related]
13. Lower regional grey matter in alcohol use disorders: evidence from a voxel-based meta-analysis.
Li L; Yu H; Liu Y; Meng YJ; Li XJ; Zhang C; Liang S; Li ML; Guo W; QiangWang ; Deng W; Ma X; Coid J; Li T
BMC Psychiatry; 2021 May; 21(1):247. PubMed ID: 33975595
[TBL] [Abstract][Full Text] [Related]
14. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
16. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
18. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
van de Pavert SH; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ridgway GR; Geurts JJ; Ron M; Yousry TA; Thompson AJ; Miller DH; Chard DT; Ciccarelli O
J Neurol Neurosurg Psychiatry; 2016 May; 87(5):461-7. PubMed ID: 25926483
[TBL] [Abstract][Full Text] [Related]
19. Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
Lansley J; Mataix-Cols D; Grau M; Radua J; Sastre-Garriga J
Neurosci Biobehav Rev; 2013 Jun; 37(5):819-30. PubMed ID: 23518268
[TBL] [Abstract][Full Text] [Related]
20. Progression of regional grey matter atrophy in multiple sclerosis.
Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]